Organ-Specific Collagen Expression: Implications for Renal Disease

Chronic kidney disease is characterized by progressive accumulation of extracellular matrix and scarring, leading to the loss of kidney function. Excess deposition of the collagen family of proteins is the hallmark of kidney fibrosis. In this review, we survey the collagens that are associated with renal disease and we highlight the use of a transgenic approach to identify cis-acting sequences in the collagen type I promoter which are capable of directing collagen type I expression specifically in the kidney. Ultimately it may be possible to use this approach to halt the accumulation of collagen selectively in this organ.

[1]  Raghu Kalluri,et al.  Bifunctional promoter of type IV collagen COL4A5 and COL4A6 genes regulates the expression of α5 and α6 chains in a distinct cell-specific fashion , 2005 .

[2]  D. Wells,et al.  Cooperativity between Far Upstream Enhancer and Proximal Promoter Elements of the Human α2(I) Collagen (COL1A2) Gene Instructs Tissue Specificity in Transgenic Mice* , 2004, Journal of Biological Chemistry.

[3]  D. Friedman,et al.  The alpha1.alpha2 network of collagen IV. Reinforced stabilization of the noncollagenous domain-1 by noncovalent forces and the absence of Met-Lys cross-links. , 2004, The Journal of biological chemistry.

[4]  A. Negri.  Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents. , 2004, Journal of nephrology.

[5]  D. Abraham,et al.  Col1a2 enhancer regulates collagen activity during development and in adult tissue repair. , 2004, Matrix biology : journal of the International Society for Matrix Biology.

[6]  N. Wahab,et al.  Connective tissue growth factor and renal diseases: some answers, more questions , 2004, Current opinion in nephrology and hypertension.

[7]  H. Anders,et al.  DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition. , 2003, Kidney international.

[8]  Y. Segal,et al.  Tissue- and developmental stage-specific activation of α5 and α6(IV) collagen expression in the upper gastrointestinal tract of transgenic mice , 2003 .

[9]  K. Tryggvason,et al.  Alport's syndrome, Goodpasture's syndrome, and type IV collagen. , 2003, The New England journal of medicine.

[10]  C. Franklin,et al.  Novel collagen glomerulopathy in a homotrimeric type I collagen mouse (oim). , 2002, Kidney international.

[11]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[12]  G. Mazzucco,et al.  COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome. , 2002, Kidney international.

[13]  D. Abraham,et al.  Identification of the Key Regions within the Mouse Pro-α2(I) Collagen Gene Far-upstream Enhancer* , 2002, The Journal of Biological Chemistry.

[14]  Junwei Yang,et al.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. , 2001, The American journal of pathology.

[15]  C. Denton,et al.  Characterization of an Evolutionarily Conserved Far-upstream Enhancer in the Human α2(I) Collagen (COL1A2) Gene* , 2001, The Journal of Biological Chemistry.

[16]  K. Kivirikko,et al.  Collagens and collagen-related diseases , 2001, Annals of medicine.

[17]  J. Rossert,et al.  Regulation of type I collagen genes expression. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  J. Rossert,et al.  Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy. , 2000, Diabetes & metabolism.

[19]  J. Miner,et al.  Renal basement membrane components. , 1999, Kidney international.

[20]  A. Ogura,et al.  Abnormalities of extracellular matrices and transforming growth factor beta1 localization in the kidney of the hereditary nephrotic mice (ICGN strain). , 1999, The Journal of veterinary medical science.

[21]  J. Kopp,et al.  Renal expression of fibrotic matrix proteins and of transforming growth factor-beta (TGF-beta) isoforms in TGF-beta transgenic mice. , 1999, Journal of the American Society of Nephrology : JASN.

[22]  Ryusuke Momota,et al.  Two genes, COL4A3 and COL4A4 coding for the human α3(IV) and α4(IV) collagen chains are arranged head‐to‐head on chromosome 2q36 1 , 1998 .

[23]  G. Jerums,et al.  Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. , 1998, Diabetes.

[24]  V. Groma,et al.  Demonstration of collagen type VI and alpha-smooth muscle actin in renal fibrotic injury in man. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  S. Peltonen,et al.  Location of type XV collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. , 1997, The American journal of pathology.

[26]  G. Magro,et al.  Immunohistochemical distribution of type VI collagen in developing human kidney , 1996, The Histochemical Journal.

[27]  R. Westendorp,et al.  Progression of chronic renal disease in humans is associated with the deposition of basement membrane components and decorin in the interstitial extracellular matrix. , 1995, Clinical nephrology.

[28]  F. Strutz,et al.  Identification and characterization of a fibroblast marker: FSP1 , 1995, The Journal of cell biology.

[29]  Rosenblum Nd,et al.  The mesangial matrix in the normal and sclerotic glomerulus. , 1994 .

[30]  M. Gubler,et al.  Collagen type III glomerulopathy: a new type of hereditary nephropathy , 1993, Pediatric Nephrology.

[31]  H. Jacobson,et al.  Mesangial deposition of type I collagen in human glomerulosclerosis. , 1992, Human pathology.

[32]  R. Hoover,et al.  Collagen polymorphism in cultured rat kidney mesangial cells. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[33]  H. D. de Wardener,et al.  Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. , 1968, Lancet.

[34]  Raghu Kalluri,et al.  Bifunctional promoter of type IV collagen COL4A5 and COL4A6 genes regulates the expression of alpha5 and alpha6 chains in a distinct cell-specific fashion. , 2005, The Biochemical journal.

[35]  Y. Segal,et al.  Tissue- and developmental stage-specific activation of alpha 5 and alpha 6(IV) collagen expression in the upper gastrointestinal tract of transgenic mice. , 2003, Biochemical and biophysical research communications.

[36]  T. Väisänen,et al.  Developmentally regulated expression of type XV collagen correlates with abnormalities in Col15a1(-/-) mice. , 2002, Matrix biology : journal of the International Society for Matrix Biology.

[37]  F. Strutz,et al.  Identification and Characterization of a Fibroblast Marker : FSP 1 , 2002 .

[38]  N. Rosenblum.  The mesangial matrix in the normal and sclerotic glomerulus. , 1994, Kidney international. Supplement.